- Fee assured
- Verified account
- Open Referral network
- Breast specialist
- Breast surgery
- Breast specialist
I am an Oncoplastic and Reconstructive Breast Surgeon and I was appointed Consultant at University College London Hospitals and Whittington Health in 2018. I obtained my Medical Degree from Athens University, where I also read for a PhD in Breast Cancer. I am Fellow of the Royal College of Surgeons of England and Fellow of the European Board of Breast Surgery, where I standard-set in the capacity of Examiner as of 2017.
I completed my higher surgical training in Greece and Belgium and was awarded my Certificate of Completion of Training in Surgery with Honours by the Athens Prefecture. I then went on to accomplish a 26-month comprehensive Oncoplastic and Reconstructive Breast Surgery Fellowship at Guy's Hospital in London, where I was subsequently appointed Consultant in 2016. I also held an Honorary Clinical Lectureship with King's College London, Division of Cancer Studies from 2015 until 2017.
I offer the full range of contemporary breast cancer surgical treatment, including complex therapeutic mammoplasty, symmetrization surgery, breast reduction and immediate sub-pectoral and pre-pectoral implant-based breast reconstruction with use of acellular dermal matrices. I have particular interest in neoadjuvant strategies, sentinel lymph node biopsy after chemotherapy and advanced oncoplastic breast conservation. I am well published internationally (2 book chapters and 40 peer-reviewed journal papers) and have been involved in Oncoplastic Training and Education of Senior Breast Surgery Trainees.
I see patients privately at the Wellington Hospital, where I provide a comprehensive, rapid-access service to assess all breast-related conditions. I speak English, Greek and French fluently.
Areas of interest
Expert Second Opinion; Advanced Oncoplastic Breast Surgery (Level I and Level II Mammoplasty); Therapeutic Reduction; Immediate sub-pectoral and pre-pectoral implant-based and acellular dermal matrix reconstruction; Risk-reducing strategies; Management of mastalgia; Sentinel lymph node biopsy; Neoadjuvant strategies; Family history risk;
Current NHS consultant posts held
University College London Hospitals
Breast cancer endocrinology (PhD thesis), sentinel biopsy and targeted axillary dissection after chemotherapy
Semi-professional piano player
(Additional) Languages spoken
- Greek, Modern - Native or bilingual
- French - Fluent
Charalampoudis P, Karakatsanis A. Neoadjuvant chemotherapy for early breast
cancer. Lancet Oncol. 2018
Spartalis E, Tsilimigras DI, Charalampoudis P, Karachaliou GS, Moris D,
Athanasiou A, Spartalis M, Bolkas V, Dimitroulis D, Nikiteas N. The "Yin and
Yang" of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or
Lumpectomy for Breast Cancer. Anticancer Res. 2017
Charalampoudis P, Markopoulos C, Kovacs T. Controversies and recommendations
regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive
review of current data. Eur J Surg Oncol. 2018
Tang SS, Kaptanis S, Charalampoudis P et al Current margin practice and effect
on re-excision rates following the publication of the SSO-ASTRO consensus and ABS
consensus guidelines: a national prospective study of 2858 women undergoing
breast-conserving therapy in the UK and Ireland. Eur J Cancer. 2017
Peek MCL, Ahmed M, Scudder J, Baker R, Charalampoudis P, Pinder SE, Douek M;
HIFU-F Collaborators. High-intensity focused ultrasound in the treatment of
breast fibroadenomata (HIFU-F trial). Int J Hyperthermia. 2017
Charalampoudis P, Agrogiannis G, Kontzoglou K, Kouraklis G, Sotiropoulos GC.
Thyroid hormone receptor alpha (TRa) tissue expression in ductal invasive breast
cancer: A study combining quantitative immunohistochemistry with digital slide
image analysis. Eur J Surg Oncol.2017
Kovacs T, Charalampoudis P, Hout BAI', Dumitru D, Kothari A. Results from the
BRIOS randomised trial. Lancet Oncol. 2017
Saporito F, Charalampoudis P, Kinney M, Knox S. Operative management of
dermatofibrosarcoma protuberans of the breast. Proc (Bayl Univ Med Cent). 2017
Peek MC, Charalampoudis P, Anninga B, Baker R, Douek M. Blue dye for
identification of sentinel nodes in breast cancer and malignant melanoma: a
systematic review and meta-analysis. Future Oncol. 2017
Charalampoudis P, Mantas D, Sotiropoulos GC, Dimitroulis D, Kouraklis G,
Markopoulos C. Surgery for liver metastases from breast cancer. Future Oncology
Markopoulos C, Charalampoudis P, Karagiannis E, Antonopoulou Z, Mantas D.
Inflammatory myofibroblastic tumor of the breast. Case Rep Surg.
- FRCS The Royal College of Surgeons of England 2015
- FEBS European Board of Breast Surgery 2016
- PhD in Breast Cancer Athens University Medical School 2018
- MD, Medical Degree Athens University Medical School 2006
- Oncoplastic and Reconstructive Breast Surgery Guy's Hospital/King's College London 2014
Reference number 6154338
Details of entry to specialist register
- Genetal Surgery Specialist Register , 2014
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Ultrasound guided biopsy(ies) - (1-5)
Unilateral image guided vacuum assisted excision of breast lesion (with biopsy) - (1-5)
Skin/nipple sparing mastectomy (including axillary node biopsy) - unilateral - (1-5)
Sentinel node mapping and sampling with blue dye or radioactive probe for breast cancer - (1-5)